United States  

U.S. commits $1.6 billion to Novavax coronavirus vaccine

CBS News Tuesday, 7 July 2020
U.S. commits $1.6 billion to Novavax coronavirus vaccineThe funding for the coronavirus vaccine candidate being developed by Novavax comes as part of Operation Warp Speed.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

What You Need to Know About Volunteering for a COVID-19 Vaccine Trial [Video]

What You Need to Know About Volunteering for a COVID-19 Vaccine Trial

Researchers are hard at work trying to develop a working vaccine for the coronavirus. But these vaccines aren’t made in a vacuum: they have to be tested out on human subjects.

Credit: Veuer     Duration: 00:59Published
Tremendous work on non-vaccine treatment: Donald Trump on US' Covid response [Video]

Tremendous work on non-vaccine treatment: Donald Trump on US' Covid response

Donald Trump, President of the United States of America, commented on the progress of research to stop the Covid-19 pandemic. Commenting on the race to develop a vaccine, he said that many companies..

Credit: HT Digital Content     Duration: 03:33Published
Trump Vaccine Therapeutics Coronavirus [Video]

Trump Vaccine Therapeutics Coronavirus

Trump Vaccine Therapeutics Coronavirus

Credit: HT Digital Content     Duration: 03:33Published

Related news from verified sources

Novavax skyrockets after US government grants $1.6 billion for coronavirus vaccine creation

Novavax skyrockets after US government grants $1.6 billion for coronavirus vaccine creation
Β· *Novavax shares spiked as much as 38% early Tuesday after receiving $1.6 billion in coronavirus vaccine funding from the US government.* Β· *The award is the...
Business Insider Also reported by •CBS NewsSeattle TimesNYTimes.comMotley Fool

Tweets about this